Completed PHASE2/PHASE3 INTERVENTIONAL 3-arm NCT01627522

Evaluation of Finastride Effect in Different Dosage on the Amount of Perioperative Bleeding in Transurthral Resection of Prostate (TURP)

Sponsor: Shiraz University of Medical Sciences

Interventions TURP

Updated 7 times since 2017 Last updated: Apr 19, 2016 Started: Jan 31, 2012 Primary completion: Mar 31, 2013 Completion: May 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Benign Prostate Hyperplasia, this trial is completed. The trial is conducted by Shiraz University of Medical Sciences and has accumulated 7 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE2/PHASE3
Sep 2025 — Present [monthly]

Completed PHASE2/PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shiraz University of Medical Sciences

Data source: Shiraz University of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shiraz, Iran